These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7103688

  • 1. Correlation of single and serial CEA determinations with the clinical evolution of cancer patients.
    de Levin RW, Levin E.
    Arch Geschwulstforsch; 1982; 52(2):105-12. PubMed ID: 7103688
    [Abstract] [Full Text] [Related]

  • 2. [Value of radioimmunological serum levels of carcinoembryonic antigen in the postoperative monitoring of rectocolonic cancer].
    Reginster JY, Desaive C, Collette J, Zangerle PF, Denis D, Franchimont P.
    Ann Gastroenterol Hepatol (Paris); 1984; 20(4):203-6. PubMed ID: 6529177
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC, Havig O.
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [Abstract] [Full Text] [Related]

  • 6. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
    Carpelan-Holmström MA, Haglund CH, Järvinen HJ, Roberts PJ.
    Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
    [Abstract] [Full Text] [Related]

  • 7. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ.
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [Abstract] [Full Text] [Related]

  • 8. CEA radioimmunoassay. Clinical applications in colorectal cancer.
    Huyghe J.
    Acta Chir Belg; 1983 Mar; 83(2):77-88. PubMed ID: 6858539
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correlation between the results of carcinoembryonal antigen (CEA) test and the clinical stage of colorectal carcinoma.
    Molnár L, Rahóty P, Bauer E, Rónay P, Besznyák I, Ottó S.
    Acta Chir Hung; 1986 Mar; 27(1):27-34. PubMed ID: 3716715
    [Abstract] [Full Text] [Related]

  • 11. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
    Tondini C, Hayes DF, Gelman R, Henderson IC, Kufe DW.
    Cancer Res; 1988 Jul 15; 48(14):4107-12. PubMed ID: 3164256
    [Abstract] [Full Text] [Related]

  • 12. [Is the clinical significance of CEA determination in patients with colorectal carcinoma exaggerated?].
    Wedell J, Meier zu Eissen P, Meier zu Eissen J, Blanco A, van Calker H, Koldowski P, Schlipköter HW.
    Med Welt; 1981 Mar 13; 32(11):343-7. PubMed ID: 7219141
    [No Abstract] [Full Text] [Related]

  • 13. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R, Farrus B, Filella X, Jo J, Zanón G, Pahisa J, Latre M, Muñoz M, Ballesta AM.
    Anticancer Res; 1999 Mar 13; 19(4A):2557-62. PubMed ID: 10470194
    [Abstract] [Full Text] [Related]

  • 14. [Clinical value of CEA studies in patients with benign and malignant breast diseases with special reference to oncologic after care].
    Kunze M, Voss P, Büttner HH, Stranz G, Strache RR.
    Zentralbl Gynakol; 1987 Mar 13; 109(24):1517-26. PubMed ID: 3442160
    [Abstract] [Full Text] [Related]

  • 15. CEA as a prognostic factor in colorectal cancer.
    Filella X, Molina R, Piqué JM, Grau JJ, Garcia-Valdecasas JC, Biete A, Novell F, Astudillo E, Bordas JM, Campo E.
    Anticancer Res; 1994 Mar 13; 14(2B):705-8. PubMed ID: 8010730
    [Abstract] [Full Text] [Related]

  • 16. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
    Yamamoto M, Maehara Y, Sakaguchi Y, Mine H, Yamanaka T, Korenaga D, Okamura T.
    Hepatogastroenterology; 2004 Mar 13; 51(55):147-51. PubMed ID: 15011851
    [Abstract] [Full Text] [Related]

  • 17. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
    Bartal AH, Ayalon D, Cordova T, Avidan S, Robinson E.
    Isr J Med Sci; 1983 Sep 13; 19(9):801-5. PubMed ID: 6643017
    [Abstract] [Full Text] [Related]

  • 18. [Carcinoembryonic antigen (CEA) in surgically treated cancer of the large intestine].
    Metzger U, Decurtins M, Joller H, Grob PJ, Largiadèr F.
    Schweiz Med Wochenschr; 1983 Apr 16; 113(15):548-9. PubMed ID: 6857209
    [Abstract] [Full Text] [Related]

  • 19. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
    Shimizu Y, Oshima K, Nakano Y, Fujita M, Taguchi T.
    Biken J; 1981 Sep 16; 24(3):95-102. PubMed ID: 6175310
    [Abstract] [Full Text] [Related]

  • 20. Value of plasma alpha-1-acid glycoprotein assay in the detection of human colorectal cancer: comparison with carcinoembryonic antigen.
    Chu CY, Lai LT, Pokala HP.
    J Natl Cancer Inst; 1982 Jan 16; 68(1):75-9. PubMed ID: 7033631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.